id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
admet-1315	Silver, Lynn	Recent advances and challenges in antibacterial drug development; The editorial	2022	2	.pdf	application/pdf	834	68	36	Recent advances and challenges in antibacterial drug development: The editorial doi: http://doi.org/10.5599/admet.1315 89 ADMET & DMPK 10(2) (2022) 89-90; doi: http://dx.doi.org/10.5599/admet.1315 Open Access : ISSN : 1848-7718 http://www.pub.iapchem.org/ojs/index.php/admet/index Editorial Recent advances and challenges in antibacterial drug development: Editorial Lynn Silver LL Silver Consulting, New Jersey, United States; silverly@comcast.net Received: March 1, 2022; Revised: March 1, 2022; Published: March 4, 2022 There is a continuing need for new antibacterial drugs to deal with the burgeoning of bacterial pathogens resistant to the existing armamentarium of antibacterial drugs, compromising their effectiveness; furthermore, emerging pathogens are now considered to be a major microbiologic public health threat. Articles in this issue include a brief review of “Recent advances and challenges in antibacterial drug development” by Valeria Gigante et al. from the WHO [5] and a review of “Old and Modern Antibiotic Structures with Potential for Today’s Infections” by David Newman [6].	cache/admet-1315.pdf	txt/admet-1315.txt